Anderson A R AR

Show results for

Unknown (964)
Transcriptomics (23)
Proteomics (10)
Genomics (6)
Genomic (1)
Metabolomics (1)

Organisms

Homo sapiens (24)
Mus musculus (5)
Mustela putorius furo (1)
Staphylococcus aureus subsp. aureus str. Newman (1)
Coprinopsis cinerea (1)
Schistosoma mansoni (1)
Oryza sativa Japonica Group (1)
Triticum aestivum (1)
Saccharomyces cerevisiae (1)
Rattus norvegicus (1)

Repository

biostudies-arrayexpress (24)
pride (8)
EGA (5)
MassIVE (2)
dbGaP (1)
MetaboLights (1)

Tissue

Cell culture (2)
Colon (2)
Embryonic stem cell (2)
Cell suspension culture (1)
Heart (1)
Lung (1)
Permanent cell line cell (1)
T cell (1)
Uterine endometrium (1)

Disease

Colitis (2)
Non-small cell lung carcinoma (1)

Technology Type

Mass Spectrometry (8)
Bottom-up proteomics (6)
Data-dependent acquisition (5)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
Mass spectrometry (1)
Gel-based experiment (1)
Top-down proteomics (1)

Instrument Platform

Orbitrap Fusion Lumos (1)
Q Exactive Plus (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2010 (7)
2025 (6)
2015 (5)
2013 (4)
2012 (2)
2011 (2)
2009 (2)
2023 (2)
2016 (1)
2014 (1)
2021 (1)
2026 (1)
2024 (1)

CHEBI ID

CHEBI:10136 (1)
CHEBI:10724 (1)
CHEBI:108580 (1)
CHEBI:116314 (1)
CHEBI:125601 (1)
CHEBI:131608 (1)
CHEBI:132244 (1)
CHEBI:132983 (1)
CHEBI:133086 (1)
CHEBI:133145 (1)
CHEBI:133176 (1)
CHEBI:133246 (1)
CHEBI:133460 (1)
CHEBI:133657 (1)
CHEBI:133672 (1)
CHEBI:134231 (1)
CHEBI:136372 (1)
CHEBI:137332 (1)
CHEBI:138367 (1)
CHEBI:138772 (1)
CHEBI:139134 (1)
CHEBI:139272 (1)
CHEBI:139382 (1)
CHEBI:140934 (1)
CHEBI:141950 (1)
CHEBI:143726 (1)
CHEBI:145236 (1)
CHEBI:145263 (1)
CHEBI:145277 (1)
CHEBI:145280 (1)

Metabolite Name

(+)-7-epi-Syringaresinol 4'-glucoside (1)
(+/-)-1-Acetoxy-1-ethoxyethane (1)
(-)-11-Hydroxy-9,15,16-trioxooctadecanoic acid (1)
(-)-Maackiain (1)
(1R,2R,4S)-p-Menthane-1,2,8-triol (1)
(1S,2S,4R,8R)-p-Menthane-1,2,9-triol (1)
(2'E,4'Z,7'Z,8E)-Colnelenic acid (1)
(2'E,4'Z,8E)-Colneleic acid (1)
(2E)-Decenoyl-ACP (1)
(2E,6Z)-2,6-Nonadien-1-Yl acetate (1)
(3beta,5alpha,6beta,22E,24R)-23-Methylergosta-7,22-diene-3,5,6-triol (1)
(4E)-1,7-bis(4-hydroxyphenyl)hept-4-en-3-one (1)
(8E,15E)-1,8,15-Heptadecatriene-11,13-diyne (1)
(9R,10S,12Z)-9,10-Dihydroxy-8-oxo-12-octadecenoic acid (1)
(9S,10E,12Z,15Z)-9-Hydroxy-10,12,15-octadecatrienoic acid (1)
(?¡À)-Sulfobutanedioic acid (1)
(Cyclohexylmethyl)pyrazine (1)
(R)-Roemerine (1)
(Z)-3-(2,4,5-Trimethoxyphenyl)-2-propenal (1)
(alpha-D-mannosyl)7-beta-D-mannosyl-diacetylchitobiosyl-L-asparagine, isoform A (protein) (1)
1,2-Cyclohexanedione (1)
1,25-Dihydroxyvitamin D3-26,23-lactone (1)
1,3-Diisopropylbenzene (1)
1-(1-Pyrrolidinyl)-2-propanone (1)
1-(2,3-Dihydro-6,7-dimethyl-1H-pyrrolizin-5-yl)-2-hydroxy-1-propanone (1)
1-(2,4-dihydroxy-6-methoxyphenyl)-3-phenylprop-2-en-1-one (1)
1-(3-Aminopropyl)-4-aminobutanal (1)
1-(3-Methyl-2-butenoyl)-6-apiosylglucose (1)
1-(beta-D-Ribofuranosyl)-1,4-dihydronicotinamide (1)
1-Acetoxy-2-hydroxy-16-heptadecyn-4-one (1)

Study type

Transcription profiling by array (20)
Comparative genomic hybridization by array (1)
ChIP-seq (1)
RNA-seq of coding RNA (1)
RNA-seq of non coding RNA (1)

Release Date

2023 (106)
2022 (88)
2021 (88)
2024 (85)
2018 (85)
2025 (82)
2015 (65)
2020 (65)
2016 (48)
2017 (46)
2019 (44)
2014 (42)
2013 (34)
2012 (26)
2010 (24)
2011 (18)
2026 (16)
2009 (13)
2008 (10)
2006 (1)
2004 (1)
2003 (1)

Lab affiliation

Cellular and Molecular Pathology, UCSF (1)
Chair of Proteomics and Bioanalytics, Technical University of Munich, Bavaria, Germany (1)
Department of Biochemistry and Pharamcology Bio21 Institute, University of Melbourne (1)
Department of Biochemistry and Pharmacology Bio21 Institute, University of Melbourne (1)
Department of Laboratory Medicine, UCSF (1)
Department of Pharmacology and Cancer Biology Duke University School of Medicine Durham, North Carolina (1)
Joseph C. Wu, MD, PhD Director, Stanford Cardiovascular Institute Simon H. Stertzer, MD, Professor of Cardiovascular Medicine & Radiology Stanford University School of Medicine Lorry I. Lokey Stem Cell Research Building 265 Campus Drive, Rm G1120B Stanford, CA 94305-5454 Phone: (650) 736-2246 (1)
Laboratory for Biological Mass Spectrometry, Biosciences Institute, Newcastle University, Newcastle-upon-Tyne, NE2 4HH, UK (1)

Previous page
1 / 101
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 101
Next page

Sort by:

Relevance

Page size

Genome-scale CRISPR screens identify PTGES3 as a direct modulator of AR function in advanced prostate cancer

The androgen receptor (AR) is a critical driver of prostate cancer (PCa). To study regulators of AR protein levels and oncogenic activity, we created the first live cell quantitative endogenous AR fluorescent reporters. Leveraging this novel AR reporter, we performed genome-scale CRISPRi flow cytome...

ORGANISM(S): Homo sapiens (Human)

2025-08-08 | PXD066297 | Pride

Ar Crispr screens Ptges3 Prostate cancer

Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma.

Not available

S-EPMC7001156 | biostudies-literature

Ligand-free mitochondria-localized mutant AR-induced cytotoxicity in spinal bulbar muscular atrophy.

Not available

S-EPMC10202391 | biostudies-literature

Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance and response in castration-resistant prostate cancer

aCGH experiment on cell-free DNA collected from the plasma of patients with castration-resistant prostate cancer. No replicates. castration-resistant prostate cancer vs male reference DNA

ORGANISM(S): Homo sapiens

2015-03-09 | E-GEOD-61134 | biostudies-arrayexpress

DNA demethylation-dependent AR recruitment and GATA factors drive Rhox5 homeobox gene transcription in the epididymis.

Not available

S-EPMC3327359 | biostudies-literature

Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation.

Not available

S-EPMC12777743 | biostudies-literature

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses.

Not available

S-EPMC6127155 | biostudies-literature

Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer.

Not available

S-EPMC12017310 | biostudies-literature

Identification of an SRF- and androgen-dependent gene signature in prostate cancer

The androgen receptor (AR) is the principal target for treatment of non-organ confined prostate cancer (PCa). Systems and bioinformatics approaches suggest that considerable variation exists in the mechanisms by which AR regulates expression of effector genes and point towards a role for secondary ...

ORGANISM(S): Homo sapiens

2011-02-28 | E-GEOD-22606 | biostudies-arrayexpress

A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.

Not available

S-EPMC8162746 | biostudies-literature

Previous page
1 / 101
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 101
Next page

Sort by:

Relevance

Page size

1005 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets